Maud Toulmonde, MD, PhD

Dr
Institut Bergonie
Bordeaux, Aquitaine, France

Disclosure information not submitted.

Presentation(s):

• Paper 21 - PHASE 1 RESULTS OF THE WEE1 INHIBITOR, AZENOSERTIB, IN COMBINATION WITH GEMCITABINE IN ADULT AND PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST